4The Post Coronary Artery Bypass Graft Trial Invesaigator. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in sapphenousvein coronary artery bypass grafts[J].N Engl J Med, 1997,336:153. 被引量：1
5Alonso R,Mata P.Sustained long-term improvement of arterial endothelial function in heterozygous familial hypercholesterolemia patients treated with simvastain[J].Atherosclerosis,2001,157:423. 被引量：1
6Laufs U,Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase Mrna stability by Rho GTPase[J].J Biol Chem,1998,273:24266. 被引量：1
7Dimmerler S,Aicher A. HMC-CoA reductase inhibitors(statins) increase endothelial progenitor cells via the PI 3-Kinase/AKt pathway[J].J Clin Invest,2001,108:391. 被引量：1
8Maat MP, Kluft C.Determinants of C-reactiove protein concentration in blood[J].Ital Heart J,2001,2:181. 被引量：1
9Dionede L,Albani D,Sottocorno M,et al. In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products[J].Arterioscler Thromb Vasc Biol,2001,21:1327. 被引量：1
10Bandoh T,Mitanni H,Nihashi M,et al. Inhibitory effect of fluvastatin at doses insufficient to lower serum lipids on the catheter-induced thickening of intima in rabbit femoral artery[J].Eur J Pharmacol,1996,315:37. 被引量：1
二级参考文献19
1Brouet A, Sonveaux P, Dessy C, et al. Hsp90 and caveolin are key targets for the proangiogenic nitic oxide-mediated effects of statins. Circ Res, 2001,89:866-873. 被引量：1
2Su SF, Hsaio CL, Chu CW, et al. Effects of pravastatin on left ventricular mass in patients with hyperlipidemia and essential hypertension. Am J Cardiol, 2000, 86:514-518. 被引量：1
3Lee TM, Chou TF, Tsai CH. Association of pravastatin and left ventricular mass in hyper- cholesterolemia patients: role of 8-Iso-Prostaglandin F2α formation. J Cardiovasc Pharmacol, 2002, 40:868-874. 被引量：1
4Luo JD, Zhang WW, Zhang GP, et al. Effects of simvastatin on left ventricular hypertrophy and function in rats with aortic stenosis. Acta Pharmacol Sin, 1999, 20: 345-348. 被引量：1
5Aikawa R, Komuro I, Yamazaki T, et al. Oxidative stress activates extracellular signal-regulated kinase through Src and Ras in culured cardiac myocytes of neonatal rats. J Clin Invest, 1997, 100:1813-1821. 被引量：1
6Bauersachs J, Galuppo P, Fraccarollo D, et al. Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction. Circulation, 2001,104 被引量：1
7Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet, 1994, 344:1383-1389. 被引量：1
8Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med, 1995, 333:1301-1307. 被引量：1
9Bonetti PO, Lerman LO, Napoli C, et al. Statin effects beyond lipid lowering-are they clinically relevant? Eur Heart J, 2003, 24:225-248. 被引量：1
10Indolfi C, Di Lorenzo E, Perrino C, et al. Hydroxy-methylglutaryl-conezyme A reductase inhibitior simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation. Circulation, 2002, 106:2118-2124. 被引量：1
